PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 3, 2026SHILAP Revista de lepidopterología0 citationsOpen Access

Defining the heterogeneous molecular landscape of lung cancer cell responses to epigenetic inhibition

View Full Paper
CLChuwei LinUniversity of WashingtonCSCatherine M SniezekUniversity of WashingtonCMChristopher D. McGannUniversity of Washington

Key Points

  • Lung cancer cell responses vary significantly to epigenetic inhibition, indicating diverse treatment possibilities.
  • A detailed characterization reveals distinct molecular pathways impacting cell reactions to therapies.
  • Analysis of biological samples showcases the heterogeneous landscape influenced by genetic and epigenetic factors.
  • These findings may enable customized therapies, highlighting the need for tailored cancer treatment strategies.
Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Lin et al. (2026) studied this question.

synapsesocial.com/papers/69a75c06c6e9836116a24637https://doi.org/10.1038/s42003-025-09455-0
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Regulation of the polarity kinases PAR-1/MARK by 14-3-3 interaction and phosphorylation2006 · 72 citations
  2. 2The 14-3-3ζ–c-Src–integrin-β3 complex is vital for platelet activation2020 · 51 citations
  3. 3UMAP: Uniform Manifold Approximation and Projection2018 · 10,110 citations
  4. 4Raise standards for preclinical cancer research2012 · 2,963 citations
  5. 5Modulation of FGF pathway signaling and vascular differentiation using designed oligomeric assemblies2024 · 57 citations